Med. Pro Praxi 2007; 4: 165-168

Hirsutizmus

MUDr. Jana Heresová CSc1,2, MUDr. Marie Vrzáňová3
1 Endokrinologický ústav, Praha
2 Klinika nukleární medicíny UK 2. LF Praha a FN Motol
3 Interní klinika fakultní nemocnice Motol a 2. lékařské fakulty Univerzity Karlovy v Praze

Hirsutizmus je patologický růst a distribuce ochlupení u žen způsobená androgenní stimulací pilosebaceosní jednotky. Příčina je multifaktoriální a závisí na etnickém nebo familiárním výskytu, hormonální poruše s nadprodukcí androgenů ve steroidogenní žláze (nadledviny, ovaria), paraendokrinní sekreci nádoru, iatrogenní příčině, genových abnormalitách aj. Výskyt zvýšené tvorby ochlupení u žen je mezi 5–10 %. Autorky rozebírají nejčastější příčiny hirsutizmu a hypertrichózy u žen jako příznaku poruchy tvorby terminálního vlasu vlivem hormonální poruchy, enzymové distribuce, metabolických, nádorových a jiných stavů. Podávají přehled současných terapeutických postupů.

Keywords: hirsutizmus, hypertrichóza, androgeny, enzymy, léčba

Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Heresová J, Vrzáňová M. Hirsutizmus. Med. praxi. 2007;4(4):165-168.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Azziz R, Carmina E, Sawaya ME. Idiopatic Hirsutism. Endocr. Rew. 2000; 21: 347-362. Go to original source...
    2. Bayram F, Muderris I, Guven M et al. Low-dose (2, 5 mg/day) finasteride treatment in hirsutism. Gynecol. Endocrinol. 2003;17(5): 419-422. Go to original source... Go to PubMed...
    3. Cibula D, Stárka L, Vrbíková J a kol. Syndrom polycystických ovarií. Praha: Jessenius - Maxdorf 2004: 110.
    4. Fait T. Klimakterická medicina. Praha: Jessenius-Maxdorf 2006: 103.
    5. Falsetti L, Gambera A, Legrenzi L, Iacobello C, Bugari G. Comparison of finasterid versus flutamide in the treatment of hirsutism. Europ. J. Endocr. 1999; 141: 361-367. Go to original source... Go to PubMed...
    6. Frank-Raue K, Junga G, Vescei P, Ziegler R. Therapy of hirsutism in females with adrenal enzyme defects of streoid hormone biosynthesis: comparison of dexamethasone with cyproterone acetate. Klin. Wochenschr. 1990; 68(12): 597-601. Go to original source... Go to PubMed...
    7. Hampel H, Kotter HU, Padberg F et al. Sever hirsutizmus with psychoframacological tretment in major depression. World J. Biol. Psychiatry 2001; 2(1): 48-49. Go to original source... Go to PubMed...
    8. Kršek M, Hána V et al. Cushingův syndrom. Praha: Galén, 2006: 144.
    9. Morrell MJ, Isojarvi J, Taylor AE et al. Higher androgens and weight gain with Valproate compared with lamotrigine for epilepsy. Epilepsy Res. 2003; 54(2-3): 189-199. Go to original source... Go to PubMed...
    10. Rosenfield RL. Hirsutism and variable response of the pilosebaceous units on androgen. J. Invest. Dermatol. Symp. Proc. 2005; 10(3): 205-208. Go to original source... Go to PubMed...
    11. Schindler E. Antiandrogenic progestins for signs of androgenisation and hormonal contraception. Clin. Endocr. 2000; 52: 587-594.
    12. Spritzer PM, Lisboa S, Mattiello S, Lhullier F. Spironolactone as a single agent for long-term therapy of hirsute patients. Eur. J. Obst. Gynecol. Repr. Biol. 2004; 112(2): 136-141.
    13. Thorin-Savoure A., Kuhn JM. Hyperandrogenism and pregnancy. Ann. Endocr. 2002; 63(5): 443-451.
    14. Tosi A, Miscali C, Piraccini BM et al. Drug-induced hair loss and hair growth. Incidence, menagement and avoidance. Drug Saf. 1994; 10(4): 310-317. Go to original source... Go to PubMed...
    15. Van der Spuy ZM, Le Roux PA. Cyproterone acetate for hirsutism. Cochrane database Syst. Rev. 2003;(4): CD001125. Go to original source...
    16. Wendelin DS, Pope DN, Mallory SB. Hypertrichosis. J. Amer. Acad. Dermatol. 2003; 48(2): 161-179. Go to original source... Go to PubMed...
    17. Zwimpfer J. Hirsutism. Polycystic ovaries with suspected metabolic syndrome. Schweitz Rundsch. Med. Prax. 1999; 86(14): 1093-1095.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.